Digital Health Europe
Open Evidence has just started its participation in DigitalHealthEurope (Support to a Digital Health and Care Innovation initiative in the context of Digital Single Market strategy), a new H2020 Coordination and Support Action (CSA). On this project Open Evidence will work together with another 16 partners from all over Europe, namely: Empirica – Gesellschaft für Kommunikations- und Technologieforschung (EMP), FUNKA Nu AB (FUNKA), Serviços Partilhados do Ministério da Saúde (SPMS), EIP on AHA Reference Sites Collaborative Network (RSCN), European Regions Research and Innovation Network (ERRIN), AGE Platform Europe (AGE), European Patients’ Forum (EPF), ECHAlliance Company (ECHA), European Institute for Health Records (EuroRec), Forschungszentrum Jülich (FZJ), European Alliance for Personalised Medicine (EAPM), European Health TelematicsAssociation (EHTEL), International Foundation for Integrated Care (IFIC), Central European Initiative (CEI) and European Coordination Committee of the Radiological and Electromedical Healthcare IT Industry (COCIR).
The objective of the project is to provide comprehensive, centralised support to the digital transformation of health and care (DTHC) priorities of the Digital Single Market. The project will support large-scale deployment of digital solutions for person-centred integrated care by identifying, analysing, and facilitating the replication of highly impactful best practices. In order to achieve this, the Consortium will make use of its expertise on knowledge management and impact assessment, twinning schemes, and mobilisation of stakeholders.
The main task of Open Evidence will be to conduct an analysis of person-centred integrated care initiatives. A preliminary list of initiatives will be identified by the Consortium via desk research. Among them, the highly impactful initiatives will be selected based on a set of factors (e.g. expected impact on the target group, scalability, availability of information, etc.). Open Evidence and the owners of the cases will then perform an impact assessment. This will be multi-dimensional and will apply the MAFEIP tool. Open Evidence has extensive experience in MAFEIP, as it has already supported the preparation of several use cases, and it is currently helping organisations to use the tool in the context of the WE4AHA project. If deemed appropriate, complementary tools will also be used, such as the SCIROCCO or MAST.
The results of this assessment are expected to shed light on the strengths and weaknesses of the initiatives, and possible areas for improvement and optimisation of costs. This will inform further design and development and will give valuable input for the twinning exchanges, which will be established to share the impactful practices with other stakeholders.